Philadelphia medical marijuana case could have nationwide impact

A federal judge in Philadelphia is considering whether to take a case that could have an enormous impact on the medical marijuana industry nationwide.

The case involves a dispensary permitted for Philadelphia Mills in the Northeast.

Pharma Cann got a state permit and city approval to open in a former Chi-Chi’s near the Mall, but mall operator, Simon Property, sued in federal court to block it from opening.

It claims the deed forbids “illegal activity” and that would include the dispensary, since marijuana is illegal under federal law.

Pharma Cann wants the issue resolved in Common Pleas Court, arguing it’s simply a case of an outdated restrictive covenant. Its attorney, Jeremy Unruh, says Simon’s attempt to make it a federal case is unduly excessive.


Pennsylvania medical marijuana dispensaries run out of supplies

Two medical marijuana dispensaries in Pennsylvania have run out of supplies — less than two weeks after the state launched its new medical marijuana program.

“We have no inventory,” Chris Visco, TerraVida Holistic Center co-owner in Bucks County, told the Philadelphia Inquirer. He said the only supplies the dispensary had left onThursday morning were vape pens.

Keystone Shops, a dispensary in Devon, posted a notice on its website saying it was closed until more products arrive.


Pennsylvania’s first week of medical marijuana sales saw high prices and long lines

Qualifying Pennsylvanians can finally buy legal medicinal cannabis products, and they’re selling out fast, even with price tags more than double of the state’s black market.

Pennsylvania’s long-awaited medical cannabis program is finally up and running, offering Keystone State residents suffering from 17 severe conditions the ability to legally purchase, possess, and consume a number of THC and CBD concentrates, topicals and tinctures.


Cannabis businesses, beware: The Hershey Co. is on the warpath.

Perhaps the most famous confectionery peddler in the world has a well-documented history of actively protecting its trademarks, and the marijuana industry is no exception.

Although Hershey's has been relatively quiet in the marijuana sector since it sued two cannabis businesses in 2014, the company seemingly ramped up its oversight of possible trademark infringements in 2017.

Hershey's — a Pennsylvania-based Fortune 500 company with annual revenue of more than $7 billion — sent cease-and-desist letters last year to at least two California marijuana companies:

Harborside, a well-established dispensary in Oakland.

Good Girl Cannabis Co., an edibles maker in rural northeast California.


Keeping medical cannabis from children is callous, and foolish

The first medical marijuana dispensaries in Pennsylvania have opened their doors over the past few days.

Thousands of patients with serious medical conditions have registered to access the drug, which comes in oils, patches and vaporisers, rather than smokable leaf form.

The historic first purchase in the state was by Diana Briggs, the mother of a teenage son with severe epilepsy. “I am beyond thrilled,” she said. “There’s no more fear, no more stress for our family.”


Philadelphia District Attorney sues Big Pharma for opioid crisis

The City of Brotherly Love is taking a stance on drug policy reform. The Philadelphia district attorney sues Big Pharma for opioid crisis.

Larry Krasner has been in office as Philadelphia District Attorney for a little over a month. He has initiated some important changes in that short time. His most recent moves are aimed at fixing some longstanding drug-related issues. Most importantly, he is suing several pharmaceutical companies for their role in the opioid crisis. As the Philadelphia District Attorney sues Big Pharma, momentum could be building to combat the epidemic.

Larry Krasner Is Suing Big Pharma


Pennsylvania will start Medical Marijuana sales this week

The state of Pennsylvania will start of medical marijuana sales this week. On Thursday, to be precise.

After months of anticipation, Pennsylvania will finally be opening the state’s first medical marijuana facilities. Gov. Tom Wolfe announced Tuesday that Pennsylvania will start medical marijuana sales this week, and the plant will be available for purchase starting on Thursday, February 15th.

The Dawn Of A New Era


Pennsylvania State University petitioning to grow industrial Hemp

Is a state university petitioning to grow industrial hemp?

As it turns out, yes! And the university in question is looking for a new location.

Penn State University has submitted an application to the State Department of Agriculture requesting that it’s fledgling hemp research program be allowed to move to Lancaster County, Pennsylvania.

The project was started on farmland near the Penn State campus at University Park, Pennsylvania in 2017.

Penn State and industrial Hemp


Researchers analyzed more than a dozen studies on how marijuana affects your heart — here's what they found

A study published in August claimed that marijuana users faced a threefold higher risk of dying from hypertension than those who had never used the drug.

The findings sounded alarming. But like any study, this one had key limitations, including the fact that it defined cannabis "users" as anyone who'd ever tried the drug. More importantly, however, it highlighted an important gap in our current understanding of the science of cannabis: How does the drug affect the heart?

A new paper highlights how clouded this picture currently is. Scientists simply don't know the overall impact of cannabis on cardiovascular health.


Pennsylvania starts signing up medical marijuana patients

Pennsylvanians moved a giant step closer Wednesday to being able to get marijuana to help treat medical conditions, as the state announced the launch of its patient and caregiver registry .

The Health Department said a pilot program was successful, leading the agency to start taking applications from people to participate in the system through a new dedicated website .

Patients are expected to be able to obtain the medication by May 1, the current target date by which the department has said it will announce its availability statewide.


Subscribe to RSS - Pennsylvania